Skip to main content
. 2016 Jun 15;14(2):722. doi: 10.18549/PharmPract.2016.02.722

Table 1.

Stage two participant location and workplace

Country
   Region
Participants Workplace setting
Hospital Community
n % n % n %
Australia
   New South Wales
   Northern Territory
   Queensland
   South Australia
   Tasmania
   Victoria
   Western Australia
10
1
3
2
1
4
3
33.3
3.3
10
6.7
3.3
13.3
10
10
1
3
1
1
4
3
33.3
3.3
10
3.3
3.3
13.3
10
-
-
-
1
-
-
-
-
-
-
3.3
-
-
-
United Kingdom
   England
3 10 3 10 - -
New Zealand 3 10 2 6.6 1 3.3
Total 30 100 28 93.4 2 6.6